AAAshley L. Ayoob

Ashley L. Ayoob

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ashley L. Ayoob has a total of 2 co-authors. Here are the top co-authors by number of shared publications:

  • Jennifer Prittie

    Department of Emergency and Critical Care Medicine, Animal Medical Center, New York, NY 10065

    2 shared publications
  • Susan G. Hackner

    Department of Emergency and Critical Care Medicine, Animal Medical Center, New York, NY 10065

    2 shared publications

Latest Publications

  • Feline babesiosis

    by Ashley L. Ayoob, Jennifer Prittie, Susan G. Hackner

    To review and summarize current information regarding the etiology, clinical presentation, diagnosis, treatment, and prognosis of feline babesiosis, especially with regard to features distinct from canine babesiosis. Babesiosis is caused by hemoprotozoa of the genus Babesia. Numerous species of Babesia exist worldwide. The babesial organism spends the majority of its life cycle within the erythrocyte of the definitive host, resulting in hemolysis, with or without systemic complications. Definitive diagnosis depends on direct visualization of the organism on blood smear or a positive polymerase chain reaction. Positive serologic tests indicate only exposure, with or without active infection. Antiprotozoal drugs and supportive care are the mainstays of therapy. Primaquine phosphate is considered the treatment of choice in cats. Prognosis depends on the severity of disease, which in turn depends on both organism and host factors. Mortality rates of 15-20% are reported.


  • Clinical management of canine babesiosis

    by Ashley L. Ayoob, Susan G. Hackner, Jennifer Prittie

    To review and summarize current information regarding epidemiology, pathogenesis, and pathophysiology leading to the various clinical syndromes associated with canine babesiosis. Diagnosis, treatment, preventative strategies, and zoonotic implications are discussed. Babesiosis is caused by hemoprotozoa of the genus Babesia. Numerous species of Babesia exist worldwide. An increased incidence of babesiosis is described, especially in North America. The babesial organism spends the majority of its life cycle within the erythrocyte of the definitive host, resulting in hemolysis, with or without systemic complications. Definitive diagnosis depends on direct visualization of the organism on blood smear or polymerase chain reaction. A positive serologic antibody test indicates exposure with or without active infection. Antiprotozoal drugs, antimicrobials, and supportive care are the mainstays of babesiosis therapy. Prognosis depends on the severity of disease, which in turn depends on both organism and host factors. Clinical syndromes associated with a poorer prognosis include red biliary syndrome, acute renal failure, acute respiratory distress syndrome, neurologic dysfunction, acute pancreatitis, cardiac dysfunction, and hypoglycemia.